GM-XANTHO topical cream

Exhibitor: XANTHO BIOTECHNOLOGY CO., LTD.

Booth No: M434

Characteristic

Xantho Biotech. founded in 2014, the company is dedicated to developing botanical new drugs for inflammatory skin disease. The company’s main product, named GM-XANTHO, is the proprietary botanical new drug topical cream, extracted active compounds from mangosteen fruit. It is developed for the treatment of atopic dermatitis and psoriasis skin diseases. The company has completed a Phase 2a human clinical trials study. The experimental results have shown that they are safe, no side effect and suitable for long term use. The company is currently planning a Phase 2b clinical study in the United States and Europe.